Browse By Person: Gunter, Jennifer
 | Up a level |
Group by: Date | Item Type
Number of items: 38.
2019
Stylianou, Nataly, Lehman, Melanie L., Wang, Chenwei, Fard, Atefeh Taherian, Rockstroh, Anja, Fazli, Ladan, et al.
(2019)
Correction: A molecular portrait of epithelial–mesenchymal plasticity in prostate cancer associated with clinical outcome.
Oncogene, 38(13), Article number: 2436 1-1.
12
1
12
1
Stylianou, Nataly, Lehman, Melanie, Wang, Chenwei, Taherian Fard, Atefeh, Rockstroh, Anja, Fazli, Ladan, et al.
(2019)
A molecular portrait of epithelial-mesenchymal plasticity in prostate cancer associated with clinical outcome.
Oncogene, 38(7), pp. 913-934.
54
10
5
54
10
5
Sarkar, Phoebe Lorraine, Lee, Wendy, Williams, Elizabeth, Lubik, Amy, Stylianou, Nataly, Shokoohmand, Ali, et al.
(2019)
Insulin enhances migration and invasion in prostate cancer cells by up-regulation of FOXC2.
Frontiers in Endocrinology, 10, Article number: 481 1-16.
32
32
Packer, Leisl, Stehbens, Samantha, Bonazzi, Vanessa, Gunter, Jennifer, Ju, Robert, Ward, Michael, et al.
(2019)
Bcl-2 inhibitors enhance FGFR inhibitor-induced mitochondrial-dependent cell death in FGFR2-mutant endometrial cancer.
Molecular Oncology, 13(4), pp. 738-756.
38
2
2
38
2
2
Subramaniam, Sugarniya, Jeet, Varinder, Clements, Judith, Gunter, Jennifer, & Batra, Jyotsna
(2019)
Emergence of microRNAs as key players in cancer cell metabolism.
Clinical Chemistry, 65(9), pp. 1090-1101.
11
6
11
6
2018
Gunter, Jennifer, Philp, Lisa, Rhee, Handoo, Lee, Wendy, Hollier, Brett, Lehman, Melanie, et al.
(2018)
Comparing adaptive prostate cancer cell metabolism following anti-androgen and biguanide treatment.
BJU International, 112(S2), p. 27.
5
5
Philp, Lisa, Rockstroh, Anja, Tevz, Gregor, Taherian Fard, Atefeh, Gunter, Jennifer, Wade, John, et al.
(2018)
Targeting leptin receptor signalling slows the progression of advanced prostate cancer.
BJU International, 122(S2), p. 25.
6
6
2017
Rhee, Handoo, Nicholson, Cheryl, Jovanovic, Lydia, Williams, Elizabeth D., Hollier, Brett G., Corcoran, Niall M., et al.
(2017)
Androgen deprivation therapy induced rise in leptin level can be reduced with metformin: Results from ADMET trial [published abstract]. In
The 18th Asia-Pacific Prostate Cancer Conference 2017, 2017-08-30 - 2017-09-02.
Tse, Brian, Volpert, Marianna, Ratther, Ellca, Stylianou, Nataly, Nouri, Mannan, McGowan, Kayla, et al.
(2017)
Neuropilin-1 is upregulated in the adaptive response of prostate tumors to androgen-targeted therapies and is prognostic of metastatic progression and patient mortality.
Oncogene, 36(24), pp. 3417-3427.
21
22
21
22
Gunter, Jennifer, Rhee, Handoo, Sarkar, Phoebe, Lee, Wendy, Philp, Lisa, Hollier, Brett, et al.
(2017)
Targeting metabolic dysfunction induced by ADT in advance prostate cancer.
Asia-Pacific Journal of Clinical Oncology, 13(S1), p. 30.
2016
Rhee, Handoo, Gunter, Jennifer H., Jovanovic, Lidija, Williams, Elizabeth D., Hollier, Brett G., Vela, Ian, et al.
(2016)
Update on androgen deprivation therapy and adjuvant metformin (ADMET) trial for men with treatment naïve metastatic prostate cancer. In
ANZUP Annual Scientific Meeting, 2016-07-10 - 2016-07-12.
Philp, Lisa, Tevz, Gregor, Sadowski, Martin, Lehman, Melanie, Gunter, Jennifer, & Nelson, Colleen
(2016)
Implicating Glucagon-like peptide-1 in the hormone-dependent metabolic reprogramming observed in advanced prostate cancer.
BJU International, 118(S1), p. 33.
5
5
Gunter, Jennifer, Sadowski, Martin, Philp, Lisa, Lee, Wendy, Sarkar, Phoebe, Lehman, Melanie, et al.
(2016)
Profiling adaptive lipid metabolism in prostate cancer cells in response to androgen deprivation and hyperinsulinaemia.
BJU International, 118(S1), p. 33.
4
4
Shah, Esha, Upadhyaya, Ash, Philp, Lisa, Tang, Tiffany, Skalamera, Duka, Gunter, Jennifer, et al.
(2016)
Repositioning 'old' drugs for new causes: identifying new inhibitors of prostate cancer cell migration and invasion.
Clinical and Experimental Metastasis, 33(4), pp. 385-399.
10
8
10
8
2015
Sadowski, Martin, Gunter, Jennifer H., Gupta, Rajesh, Blanksby, Stephen J., & Nelson, Colleen C.
(2015)
Investigation of deregulated lipid metabolism in advanced prostate cancer. In
2nd Prostate Cancer World Congress, 2015-08-17 - 2015-08-21.
Rhee, Handoo, Gunter, Jennifer, Heathcote, Peter, Ho, Ken, Stricker, Phillip, Corcoran, Niall, et al.
(2015)
Adverse effects of androgen-deprivation therapy in prostate cancer and their management.
BJU International, 115(S5), pp. 3-13.
62
54
62
54
Rhee, Handoo, Vela, Ian, Gunter, Jennifer, Jovanovic, Lidija, Hollier, Brett, Williams, Elizabeth, et al.
(2015)
Clinical application of biomarkers in prostate cancer in men with metabolic syndrome project: Clinical evaluation of prognostic and metabolic benefits of Metformin in prostate cancer. In
Urological Society of Australia and New Zealand 68th Annual Scientific Meeting, 2015-04-11 - 2015-04-14.
Sweeney, Katrina, Stylianou, Nataly, Tevz, Gregor, Pirlo, Katrina, Upadhyaya, Akanksha, Lehman, Melanie, et al.
(2015)
Elucidating the role of ZEB1 in metastatic castration resistant prostate cancer. In
2nd Prostate Cancer World Congress, 2015-08-17 - 2015-08-21.
Rhee, Handoo, Gunter, Jennifer, Jovanovic, Lidija, Williams, Elizabeth, Hollier, Brett, Vela, Ian, et al.
(2015)
Enrichment and propagation of circulating tumour cells in men with hormone naive metastatic prostate cancer (Conference Abstract).
BJU International, 116(S1), p. 33.
Gunter, Jennifer, Lee, Wendy, Philp, Lisa, Sarkar, Phoebe Lorraine, Hollier, Brett, Sadowski, Martin, et al.
(2015)
Insulin increases apoptotic resistance in prostate cancer cells, but are sensitised by metformin.
BJU International, 116(Suppl S1), p. 43.
7
7
Philp, Lisa, Gunter, Jennifer H., Sadowski, Martin C., Tevz, Gregor, Lehman, Melanie, Otvos Jnr, Laszlo, et al.
(2015)
Leptin receptor antagonist, Allo-Aca, prevents migration, invasion and modifies lipogenesis pathways in prostate cells. In
2nd Prostate Cancer World Congress, 2015-08-17 - 2015-08-21, Cairns, Qld, Australia.
Hollier, Brett G., Stylianou, Nataly, Jovanovic, Lidija, Wang, Chenwei, Lehman, Melanie, Sadowski, Martin, et al.
(2015)
The mesenchymal-to-epithelial reverting transition is enriched in metastatic castration resistant prostate cancer and correlates with poor survival. In
2nd Prostate Cancer World Congress, 2015-08-17 - 2015-08-21, Cairns, Qld, Australia.
29
29
Volpert, Marianna, Tse, Brian W.C., Stylianou, Nataly, Ratther, Ellca, McPherson, Stephen, Costa, Taylor, et al.
(2015)
Targeting neuropilin-1 to inhibit prostate cancer invasion and metastasis. In
2nd Prostate Cancer World Congress, 2015-08-17 - 2015-08-21, Cairns, Qld, Australia.
36
36
2014
Sadowski, Martin, Pouwer, Rebecca, Gunter, Jennifer, Lubik, Amy, Quinn, Ronald, & Nelson, Colleen
(2014)
The fatty acid synthase inhibitor triclosan: repurposing an anti-microbial agent for targeting prostate cancer.
OncoTarget, 5(19), pp. 9362-9381.
245
67
67
245
67
67
2013
Tevz, Gregor, Lehman, Melanie, Lai, John, An, Jiyuan, Wang, Chenwei, Gunter, Jennifer H., et al.
(2013)
Androgen responsive non-coding RNA regulates the expression of prostate cancer associated CTBP1in LNCaP. In
Prostate Cancer World Congress & 14th Australasian Prostate Cancer Conference, 2013-08-06 - 2013-08-10.
Stylianou, Nataly, Kashyap, Abhishek S., Jovanovic, Lydia, Lehman, Melanie, Wang, Chenwei, Gunter, Jennifer H., et al.
(2013)
Investigating the epithelial to mesenchymal transition in prostate cancer invasion and metastasis. In
Prostate Cancer World Congress & 14th Australasian Prostate Cancer Conference, 2013-08-06 - 2013-08-10.
Lubik, Amy, Gunter, Jennifer, Hollier, Brett, Ettinger, Susan, Fazli, Ladan, Stylianou, Nataly, et al.
(2013)
IGF2 increases de novo steroidogenesis in prostate cancer cells.
Endocrine-Related Cancer, 20(2), pp. 173-186.
31
26
31
26
Gunter, Jennifer, Sarkar, Phoebe Lorraine, Lubik, Amy, & Nelson, Colleen
(2013)
New players for advanced prostate cancer and the rationalisation of insulin-sensitising medication.
International Journal of Cell Biology, 2013, pp. 1-13.
1,043
17
1,043
17
Hollier, Brett, Stylianou, Nataly, Kashyap, Abhishek, Jovanovic, Lidija, Lehman, Melanie, Wang, Chenwei, et al.
(2013)
Targeting epithelial-mesenchymal plasticity for improved treatments of advanced prostate cancer (Conference Abstract).
BJU International Supplement, 112(S1), pp. 45-46.
2012
Thomas, Elaine C., Gunter, Jennifer H., Webster, Julie A., Schieber, Nicole L., Oorschot, Viola, Parton, Robert G., et al.
(2012)
Different characteristics and nucleotide binding properties of inosine monophosphate dehydrogenase (IMPDH) isoforms.
PLoS One, 7(12), Article number: e51096 1-14.
10
39
37
10
39
37
Gunter, Jennifer, Lubik, Amy, Mckenzie, Ian, Pollak, Michael, & Nelson, Colleen
(2012)
The interactions between insulin and androgens in progression to castrate-resistant prostate cancer.
Advances in Urology, 2012, pp. 1-11.
275
16
1
275
16
1
2011
Lubik, Amy, Gunter, Jennifer, Hendy, Stephen, Locke, Jennifer, Adomat, Hans, Thompson, Vanessa, et al.
(2011)
Insulin increases de novo steroidogenesis in prostate cancer cells.
Cancer Research, 71(17), pp. 5754-5764.
54
83
77
54
83
77
2010
Cnop, M., Hughes, S. J., Igoillo-Esteve, M., Hoppa, M. B., Sayyed, F., Van De Laar, L., et al.
(2010)
The long lifespan and low turnover of human islet beta cells estimated by mathematical modeling of lipofuscin accumulation.
Diabetologia, 53(2), pp. 321-330.
127
127
2009
Su, Hua, Gunter, Jennifer H., de Vries, Melissa, Connor, Tim, Wanyonyi, Stephen, Newell, Felicity S., et al.
(2009)
Inhibition of inosine monophosphate dehydrogenase reduces adipogenesis and diet-induced obesity.
Biochemical and Biophysical Research Communications, 386(2), pp. 351-355.
7
6
7
6
2008
Gunter, Jennifer H., Thomas, Elaine C., Lengefeld, Nadia, Kruger, Sarah J., Worton, Leah, Gardiner, Edith M., et al.
(2008)
Characterisation of inosine monophosphate dehydrogenase expression during retinal development: Differences between variants and isoforms.
International Journal of Biochemistry and Cell Biology, 40(9), pp. 1716-1728.
33
32
33
32
2005
Moffitt, J. H., Fielding, B. A., Evershed, R., Berstan, R., Currie, J. M., & Clark, A.
(2005)
Adverse physicochemical properties of tripalmitin in beta cells lead to morphological changes and lipotoxicity in vitro.
Diabetologia, 48(9), pp. 1819-1829.
86
86
Esapa, Christopher, Moffitt, Jennifer H., Novials, Anna, McNamara, Catherine M., Levy, Jonathan C., Laakso, Marku, et al.
(2005)
Islet amyloid polypeptide gene promoter polymorphisms are not associated with Type 2 diabetes or with the severity of islet amyloidosis.
Biochimica et Biophysica Acta - Molecular Basis of Disease, 1740(1), pp. 74-78.
8
9
8
9
2003
Powell, D. S., Maksoud, H., Chargé, S. B.P., Moffitt, J. H., Desai, M., Da Silva Fihlo, R. L., et al.
(2003)
Apolipoprotein E genotype, islet amyloid deposition and severity of Type 2 diabetes.
Diabetes Research and Clinical Practice, 60(2), pp. 105-110.
15
12
15
12